Time to SARS-CoV-2 clearance among patients with cancer and COVID-19.

Wenxin XuAndrew J Piper-VallilloPoorva BindalJonathan WischhusenJaymin M PatelDaniel B CostaMary Linton B Peters

Published in: Cancer medicine (2021)

SARS-CoV-2 clearance times differ substantially depending on the criteria used and may be prolonged in cancer patients. This could lead to a delay in cancer care, increased use of clearance testing, and extension of infection control precautions.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease